: This study demonstrates that 3-HAA sensitizes HCC cells to sorafenib by upregulation of phosphatases, suggesting it as a promising molecule for HCC therapy.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: